Ardent Health (NYSE:ARDT) Price Target Raised to $13.50

Ardent Health (NYSE:ARDT) had its price target boosted by analysts at UBS Group from $13.00 to $13.50 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s price objective would indicate a potential upside of 36.71% from the company’s current price.

A number of other equities research analysts also recently issued reports on ARDT. Leerink Partners reduced their price objective on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Royal Bank Of Canada cut their price objective on Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, March 9th. Finally, JPMorgan Chase & Co. lowered their target price on Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th. Seven research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $14.21.

Ardent Health Stock Up 5.4%

Shares of ARDT stock traded up $0.51 during trading hours on Thursday, reaching $9.88. The company had a trading volume of 727,156 shares, compared to its average volume of 399,018. The company has a market cap of $1.41 billion, a price-to-earnings ratio of 10.39 and a beta of 0.93. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.97 and a quick ratio of 1.85. Ardent Health has a 12 month low of $8.07 and a 12 month high of $15.48. The business has a fifty day simple moving average of $9.26 and a 200-day simple moving average of $9.79.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.10. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a return on equity of 14.01% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, research analysts expect that Ardent Health will post 1.11 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Several institutional investors have recently made changes to their positions in the stock. Goldentree Asset Management LP lifted its holdings in Ardent Health by 99.7% during the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after purchasing an additional 1,150,000 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after buying an additional 724,841 shares during the period. Ameriprise Financial Inc. lifted its holdings in shares of Ardent Health by 75.6% in the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after buying an additional 703,739 shares in the last quarter. Bridgeway Capital Management LLC lifted its holdings in shares of Ardent Health by 108.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after buying an additional 491,961 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in shares of Ardent Health in the third quarter valued at approximately $6,377,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.